<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">52384</article-id><article-id pub-id-type="doi">10.7554/eLife.52384</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-159673"><name><surname>Durham</surname><given-names>Natasha D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159674"><name><surname>Agrawal</surname><given-names>Aditi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159675"><name><surname>Waltari</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-55280"><name><surname>Croote</surname><given-names>Derek</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4907-1865</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-159676"><name><surname>Zanini</surname><given-names>Fabio</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7097-8539</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-159678"><name><surname>Fouch</surname><given-names>Mallorie</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159677"><name><surname>Davidson</surname><given-names>Edgar</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159679"><name><surname>Smith</surname><given-names>Olivia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159680"><name><surname>Carabajal</surname><given-names>Esteban</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159681"><name><surname>Pak</surname><given-names>John E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159682"><name><surname>Doranz</surname><given-names>Benjamin J</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159683"><name><surname>Robinson</surname><given-names>Makeda</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159684"><name><surname>Sanz</surname><given-names>Ana M</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159685"><name><surname>Albornoz</surname><given-names>Ludwig L</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159686"><name><surname>Rosso</surname><given-names>Fernando</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100117"><name><surname>Einav</surname><given-names>Shirit</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6441-4171</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-3886"><name><surname>Quake</surname><given-names>Stephen R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1613-0809</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-159688"><name><surname>McCutcheon</surname><given-names>Krista M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" corresp="yes" id="author-159250"><name><surname>Goo</surname><given-names>Leslie</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3866-6735</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf8"/></contrib><aff id="aff1"><institution content-type="dept">Infectious Disease Initiative</institution>, <institution>Chan Zuckerberg Biohub</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Bioengineering</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Integral Molecular, Inc</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Medicine</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Clinical Research Center</institution>, <institution>Fundación Valle del Lili</institution>, <addr-line><named-content content-type="city">Cali</named-content></addr-line>, <country>Colombia</country></aff><aff id="aff6"><institution content-type="dept">Pathology and Laboratory Department</institution>, <institution>Fundación Valle del Lili</institution>, <addr-line><named-content content-type="city">Cali</named-content></addr-line>, <country>Colombia</country></aff><aff id="aff7"><institution content-type="dept">Vaccine and Infectious Disease Division</institution>, <institution>Fred Hutchinson Cancer Research Center</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-43030"><name><surname>Sawyer</surname><given-names>Sara L</given-names></name><role>Reviewing editor</role><aff><institution>University of Colorado Boulder</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>lgoo@fredhutch.org</email> (LG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>10</day><month>12</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e52384</elocation-id><history><date date-type="received"><day>03</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>09</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Durham et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Durham et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-52384-v1.pdf"/><abstract><p>Eliciting broadly neutralizing antibodies (bNAbs) against the four dengue virus serotypes (DENV1-4) that are spreading into new territories is an important goal of vaccine design. To define bNAb targets, we characterized 28 antibodies belonging to expanded and hypermutated clonal families identified by transcriptomic analysis of single plasmablasts from DENV-infected individuals. Among these, we identified J9 and J8, two somatically related bNAbs that potently neutralized DENV1-4. Mutagenesis studies showed that the major recognition determinants of these bNAbs are in E protein domain I, distinct from the only known class of human bNAbs against DENV with a well-defined epitope. B cell repertoire analysis from acute-phase peripheral blood suggested that J9 and J8 followed divergent somatic hypermutation pathways, and that a limited number of mutations was sufficient for neutralizing activity. Our study suggests multiple B cell evolutionary pathways leading to DENV bNAbs targeting a new epitope that can be exploited for vaccine design.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Chan Zuckerberg Biohub</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Durham</surname><given-names>Natasha D</given-names></name><name><surname>Agrawal</surname><given-names>Aditi</given-names></name><name><surname>Waltari</surname><given-names>Eric</given-names></name><name><surname>Zanini</surname><given-names>Fabio</given-names></name><name><surname>Smith</surname><given-names>Olivia</given-names></name><name><surname>Carabajal</surname><given-names>Esteban</given-names></name><name><surname>Pak</surname><given-names>John E</given-names></name><name><surname>Quake</surname><given-names>Stephen R</given-names></name><name><surname>McCutcheon</surname><given-names>Krista M</given-names></name><name><surname>Goo</surname><given-names>Leslie</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005895</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Goo</surname><given-names>Leslie</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HHSN272201400058C</award-id><principal-award-recipient><name><surname>Doranz</surname><given-names>Benjamin J</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>NSF Graduate Research Fellowship</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Croote</surname><given-names>Derek</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Kou-I Yeh Stanford Graduate Fellowship</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Croote</surname><given-names>Derek</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Catalyst Award from Dr Ralph and Marian Falk Medical Research Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Einav</surname><given-names>Shirit</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Stanford Bio-X Interdisciplinary Initiatives Seed Grants Program</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Einav</surname><given-names>Shirit</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution>Stanford Advanced Residency Training at Stanford Fellowship Program</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Robinson</surname><given-names>Makeda</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Eric Waltari, Inventor of the following patent application, which is co-owned by the Chan Zuckerberg Biohub and Stanford University: PCT patent application entitled ANTIBODIES AGAINST DENGUE VIRUS AND RELATED METHODS, Serial no. PCT/US2019/045427, filed August 7, 2019.</p></fn><fn fn-type="conflict" id="conf3"><p>Derek Croote, Inventor of the following patent application, which is co-owned by the Chan Zuckerberg Biohub and Stanford University: PCT patent application entitled ANTIBODIES AGAINST DENGUE VIRUS AND RELATED METHODS, Serial no. PCT/US2019/045427, filed August 7, 2019.</p></fn><fn fn-type="conflict" id="conf4"><p>Fabio Zanini, Inventor of the following patent application, which is co-owned by the Chan Zuckerberg Biohub and Stanford University: PCT patent application entitled ANTIBODIES AGAINST DENGUE VIRUS AND RELATED METHODS, Serial no. PCT/US2019/045427, filed August 7, 2019.</p></fn><fn fn-type="conflict" id="conf5"><p>Shirit Einav, Inventor of the following patent application, which is co-owned by the Chan Zuckerberg Biohub and Stanford University: PCT patent application entitled ANTIBODIES AGAINST DENGUE VIRUS AND RELATED METHODS, Serial no. PCT/US2019/045427, filed August 7, 2019.</p></fn><fn fn-type="conflict" id="conf6"><p>Stephen R Quake, Inventor of the following patent application, which is co-owned by the Chan Zuckerberg Biohub and Stanford University: PCT patent application entitled ANTIBODIES AGAINST DENGUE VIRUS AND RELATED METHODS, Serial no. PCT/US2019/045427, filed August 7, 2019.</p></fn><fn fn-type="conflict" id="conf7"><p>Krista M McCutcheon, Inventor of the following patent application, which is co-owned by the Chan Zuckerberg Biohub and Stanford University: PCT patent application entitled ANTIBODIES AGAINST DENGUE VIRUS AND RELATED METHODS, Serial no. PCT/US2019/045427, filed August 7, 2019.</p></fn><fn fn-type="conflict" id="conf8"><p>Leslie Goo, Inventor of the following patent application, which is co-owned by the Chan Zuckerberg Biohub and Stanford University: PCT patent application entitled ANTIBODIES AGAINST DENGUE VIRUS AND RELATED METHODS, Serial no. PCT/US2019/045427, filed August 7, 2019.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study was approved by the Stanford University Administrative Panel on Human Subjects in Medical Research (Protocol #35460) and the Fundación Valle del Lili Ethics committee in biomedical research (Cali, Colombia). All subjects, their parents, or legal guardians provided written informed consent, and subjects between 6 to 17 years of age and older provided assent.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2, 4, and 6.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Zanini F</collab><collab>Robinson ML</collab><collab>Croote D</collab><collab>Sahoo MK</collab><collab>Sanz AM</collab><collab>Ortiz-Lasso E</collab><collab>Albornoz LL</collab><collab>Suarez FR</collab><collab>Montoya JG</collab><collab>Goo L</collab><collab>Pinsky BA</collab><collab>Quake SR</collab><collab>Einav S</collab></person-group><year iso-8601-date="2019">2019</year><source>In vivo molecular signatures of severe dengue infection revealed by viscRNA-Seq</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116672">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116672</ext-link><comment>NCBI Gene Expression Omnibus, GSE116672</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-52384-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>